Results 41 to 50 of about 112,073 (304)
Therapeutic Advances in Gastroenterology, 2021 Introduction: The optimal approach to screening and risk stratification for non-alcoholic fatty liver disease is challenging given disease burden and variable progression. The aim of this study was to assess primary care physician and referring physician
Naba Saeed +6 more
doaj +1 more source
Non-alcoholic fatty liver disease and liver secretome
Archives of Pharmacal Research, 2022 Metabolism of carbohydrates and lipids and protein degradation occurs in the liver and contributes to the body's homeostasis by secreting a variety of mediators. Any imbalance in this homeostasis due to excess fat consumption and the pathologic events accompanying lipotoxicity, autophagy dysregulation, endoplasmic reticulum stress, and insulin ...
Muhammad Sohaib Khan +2 more
openaire +2 more sources
Platelets in Non-alcoholic Fatty Liver Disease [PDF]
Frontiers in Pharmacology, 2022 Non alcoholic steatohepatitis (NASH) is the inflammatory reaction of the liver to excessive accumulation of lipids in the hepatocytes. NASH can progress to cirrhosis and hepatocellular carcinoma (HCC). Fatty liver is the hepatic manifestation of metabolic syndrome.
Andrea Dalbeni +6 more
openaire +3 more sources
Frontiers in Molecular Biosciences, 2022 Background and Objective: Although growing evidence indicates that non-alcoholic fatty liver disease is related to diabetic retinopathy (DR), research results significantly vary.
Guo-heng Zhang +7 more
doaj +1 more source
Heterogeneity of non‐alcoholic fatty liver disease [PDF]
Liver International, 2015 See Article on Page ...
Yki‐Järvinen, Hannele +1 more
openaire +2 more sources
Pathology of non-alcoholic fatty liver disease
Pathologica, 2021 Non-alcoholic fatty liver disease (NAFLD) encompasses a spectrum of different conditions which are characterized by hepatic steatosis in the absence of secondary causes. It is currently the most common chronic liver disease worldwide, and its estimated prevalence is about 1.5-6.5%.
Cataldo, Ivana +7 more
openaire +4 more sources
How big a problem is non-alcoholic fatty liver disease? [PDF]
, 2011 This is one of a series of occasional articles that highlight areas of practice where management lacks convincing supporting ...
McPherson, Stuart +5 more
core +1 more source
Non-alcoholic fatty liver disease: current aspects of diagnosis in real clinical practice
, 2021 In the diagnosis and subsequent supervision of patients with non-alcoholic fatty liver disease (NAFLD) and obesity in real clinical practice, the role and importance of the doctor of first contact (therapist and general practitioner) increases.
Dmitry I. Trukhan
core +1 more source
مجلة كلية الطب, 2018 Background: Non-alcoholic fatty liver disease (NAFLD) is a very common liver disease in the world, particularly in Western and developed countries. It is rapidly growing in the Asia- Pacific region.
Abdul Sattar A. Khammas +7 more
doaj +1 more source
Macrophage Activation in Pediatric Nonalcoholic Fatty Liver Disease (NAFLD) Correlates with Hepatic Progenitor Cell Response via Wnt3a Pathway. [PDF]
PLoS ONE, 2016 Non-alcoholic fatty liver disease is one of the most important causes of liver-related morbidity in children. In non-alcoholic fatty liver disease, the activation of liver resident macrophage pool is a central event in the progression of liver injury ...
Guido Carpino +10 more
doaj +1 more source